Patents Examined by Janice Y Silverman
  • Patent number: 11957815
    Abstract: An artificial tissue construct for nerve repair and regeneration includes a biocompatible and biodegradable nerve guidance matrix comprising a plurality of biopolymers that include chitosan, gelatin, collagen and hyaluronic acid. A cross-linker includes glutaraldehyde. The nerve guidance matrix is formed as a three-dimensional scaffold polyelectrolyte complex (PEC). A subconfluent and grown monolayer of at least one of human mesenchymal stem cells, mesenchymal stem cells, differentiated Schwann cells and neuronal cells is on the biocompatible and biodegradable nerve guidance matrix for direct implantation or delivery. A method of making the artificial tissue construct is disclosed.
    Type: Grant
    Filed: November 12, 2020
    Date of Patent: April 16, 2024
    Assignee: DATT LIFE SCIENCES PRIVATE LIMITED
    Inventors: Rajan Datt, Siddharth Pandey, Poonam Meena, Mukesh Kumar, Nitin Khatri, Rakesh Kumar Nagar
  • Patent number: 11944640
    Abstract: The invention relates to pharmaceutical compositions comprising a zinc2+ salt and a ?-polyglutamic acid carrier, and, optionally, an NF-kB inhibitor as a tumor-sensitizing agent, and methods for using such compositions to treat tumors in patients. Methods include administering a liquid dosage form or a solid dosage form of a therapeutically effective amount of a Zn(II) salt and a ?-polyglutamic acid carrier to a patient in need thereof. Methods of treating a broad spectrum of human tumors, including tumors with a drug-resistant phenotype, using the disclosed compositions are provided. Tumors that respond to the pharmaceutical compositions disclosed herein include neuroendocrine (neuroblastoma), gastric, uterine, and lung tumors.
    Type: Grant
    Filed: October 31, 2017
    Date of Patent: April 2, 2024
    Assignee: XYLONIX PTE. LTD.
    Inventor: Jinhyuk Fred Chung
  • Patent number: 11944655
    Abstract: The invention is directed to a microcapsule and the method to obtain it. The microcapsule comprises a core in the form of a lipid sphere coated by a protein film, wherein the lipid sphere comprises sporulated microorganisms and at least one lipid wall material, and the protein film is a mix of carbohydrate, protein material and water. The method to obtain this microcapsule includes the stages of mixing sphere components, mixing protein film components, homogenizing the protein film and the subsequent coating of the lipid sphere by means of fluidization with the protein film.
    Type: Grant
    Filed: September 30, 2020
    Date of Patent: April 2, 2024
    Assignee: Alpina Productos Alimenticios, S.A.
    Inventors: Bernadette Francisca Klotz Ceberio, Maria Ximena Quintanilla Carvajal
  • Patent number: 11937602
    Abstract: Antimicrobial compositions including at least one acid and at least one anionic surfactant are provided. In particular, food contact antimicrobial compositions including at least one acid and at least one anionic surfactant provide efficacious virucidal activity, including against Norovirus, having acceptable use solution pH that do not require use of personal protective equipment (PPE), are surface compatible and do not leave residues on treated surfaces. Methods of cleaning a surface with the compositions are also provided and may beneficially eliminate the need to rinse the antimicrobial compositions after use.
    Type: Grant
    Filed: September 26, 2018
    Date of Patent: March 26, 2024
    Assignee: ECOLAB USA INC.
    Inventors: Wendy Lo, Derrick Anderson, Erik Olson, Catherine Hanson, Junzhong Li, David D. McSherry, Stacy Fawbush, Kaitlin Lake, Gerard Hinrichs, Joshua Luedtke, Richard Staub
  • Patent number: 11920162
    Abstract: Ex-vivo culture systems are provided. Accordingly there is provided a culture system comprising a culture medium and a precision-cut tissue slice placed on a tissue culture insert, wherein the precision-cut tissue slice is maintained in a highly oxygenated atmosphere containing at least 50% oxygen and wherein said culture is rotationally agitated facilitating intermittent submersion of the tissue slice in the culture medium. Also provided are methods of culturing a tissue and methods of using the culture system for selecting a drug for the treatment of a disease.
    Type: Grant
    Filed: April 3, 2018
    Date of Patent: March 5, 2024
    Assignee: Yeda Research and Development Co. Ltd.
    Inventors: Ravid Straussman, Nancy Gavert
  • Patent number: 11910793
    Abstract: Multifunctional agricultural adjuvant compositions (“MAACs”) include at least one liquid component and one or more solid agricultural particles dispersed in the liquid component. The liquid component may include at least one methylated seed oil. Examples of the solid agricultural particles include ammonium sulfate, other water conditioners, amino acids, or polymers. The MAAC exhibits one or more desired functions depending on the quantity and composition of the liquid component, the quantity and composition of the solid agricultural particles, and, optionally, adding one or more surfactants and/or one or more additional components (e.g., rheology modifiers) to the MAAC. The desired functions of the MAAC may include at least one of a water conditioner, a surfactant, a high surfactant oil concentrate, a crop oil concentrate, or a drift reduction and a deposition adjuvant.
    Type: Grant
    Filed: January 23, 2020
    Date of Patent: February 27, 2024
    Assignee: WinField Solutions, LLC
    Inventors: Christine M. Colby, Elizabeth Alonzi, Danny M. Brown
  • Patent number: 11905304
    Abstract: Agricultural products, such as pesticides, plant growth regulators, fungicides, herbicides, and insecticides, may be formulated to include one or more surfactants, from one or more surfactant classes, such as siloxane derivatives of amino acids that have surface-active properties.
    Type: Grant
    Filed: December 10, 2020
    Date of Patent: February 20, 2024
    Assignee: AdvanSix Resins & Chemicals LLC
    Inventor: Edward Asirvatham
  • Patent number: 11890381
    Abstract: A present invention relates to a natural lubricant composition, a tablet comprising a natural lubricant composition and a preparation method thereof. The Natural Lubricant composition for a tablet comprises an active lubricant ingredient selected from a corn flour, a corn starch, and an arrowroot flour. The Natural Lubricant composition for a tablet also comprises a natural oil.
    Type: Grant
    Filed: September 8, 2021
    Date of Patent: February 6, 2024
    Assignee: NITIKA PHARMACEUTICAL SPECIALITIES PVT. LTD.
    Inventor: Ravleen Singh Khurana
  • Patent number: 11882834
    Abstract: Compounds of the formula (I), (I) wherein the substituents are as defined in claim 1, useful as pesticides, and especially fungicides.
    Type: Grant
    Filed: November 27, 2018
    Date of Patent: January 30, 2024
    Assignee: SYNGENTA PARTICIPATIONS AG
    Inventors: Martin Pouliot, Stefano Rendine
  • Patent number: 11884781
    Abstract: The present invention relates to supramolecular biomedical polymers comprising quadruple hydrogen bonding units and to a process for preparing such a supramolecular biomedical polymer and porous biomedical implants thereof. The supramolecular biomedical polymers are particularly suitable for the production of porous biomedical implants that need high strength, elasticity, durability, and slow biodegradation, e.g. medical implants for living tissue regeneration within a mammal, such as the treatment of cardio-vascular diseases, medical prolapses, and hernias.
    Type: Grant
    Filed: May 19, 2020
    Date of Patent: January 30, 2024
    Assignee: SUPRAPOLIX B.V.
    Inventors: Tristan Mes, Anton Willem Bosman, Joris Wilhelmus Peeters, Henricus Marie Janssen
  • Patent number: 11865206
    Abstract: The present invention relates to a ready-to-use solution of carmustine that does not require dissolution or dilution of the carmustine prior to addition to saline and dextrose parenteral solutions. In particular, the invention relates to a stable liquid pharmaceutical composition containing carmustine in the form of ready-to-use solution and method for preparing the same.
    Type: Grant
    Filed: December 28, 2022
    Date of Patent: January 9, 2024
    Assignee: EMCURE PHARMACEUTICALS LTD
    Inventors: Sougata Pramanick, Aasiya Aslam Burhan, Mukund Keshav Gurjar, Hiren Pravinbhai Patel, Deepak Pragjibhai Gondaliya
  • Patent number: 11802241
    Abstract: Methods of increasing soil water content are described. The methods may include applying a soil enhancement agent to the soil, where the soil enhancement agent includes one or both of (i) lactobionic acid and (ii) at least one salt of lactobionic acid. Treated soils with increased soil water content are also described. The treated soils may include a soil enhancement agent absorbed into the soil. The soil enhancement agent may include at least one salt of a lactobionic acid. Cations from the at least one salt of a lactobionic acid may aggregate at least a portion of the particles in the soil.
    Type: Grant
    Filed: July 9, 2018
    Date of Patent: October 31, 2023
    Assignee: Leprino Foods Company
    Inventor: Richard K. Merrill
  • Patent number: 11761949
    Abstract: A method for assessing susceptibility to nausea of a patient comprises assessing the GSH recycling dependent antioxidant activity of the patient's blood cells prior to receiving an emetogenic agent, e.g., a cytostatic agent or a surgical anesthetic.
    Type: Grant
    Filed: October 9, 2017
    Date of Patent: September 19, 2023
    Assignee: Lankenau Institute for Medical Research
    Inventor: Margaretha Wallon
  • Patent number: 11723878
    Abstract: Implementations set forth herein relate to systems, methods, and apparatuses associated with fullerene-containing materials. In some implementations, a fullerene-containing material is disposed over a substrate of a smoke-able product in order to inhibit an allergic response (e.g., coughing) from a user who smokes or otherwise ingests the smoke-able product. Various fullerene-containing materials can be generated using a carbon substance that undergoes one or more process operations in order for fullerene molecules to be available for inclusion in the various materials. In some implementations, one or more other fullerene-containing materials can be generated through an at least partially organic process of feeding a particular plant a fullerene-containing plant food.
    Type: Grant
    Filed: December 21, 2020
    Date of Patent: August 15, 2023
    Inventor: Aaron Self
  • Patent number: 11696886
    Abstract: Provided is a cosmetic having a unique soft and springy feeling in use, capable of stably formulating therein a UV protector, and providing a light feeling in use such that the cosmetic is separated into pieces when applied to the skin. The present invention relates to a cosmetic characterized by comprising (A) a (meth)acrylic acid/an alkyl (meth)acrylate/a (meth)acrylic acid-POE monoalkyl ether ester copolymer, (B) a UV protector, (C) a nonionic surfactant, and (D) a higher alcohol.
    Type: Grant
    Filed: May 30, 2018
    Date of Patent: July 11, 2023
    Assignee: SHISEIDO COMPANY, LTD.
    Inventors: Daiki Arai, Hideki Shimizu, Tetsuro Yonezawa
  • Patent number: 11678669
    Abstract: Process for conferring a protection against a pathogen upon a plant by elicitation by an aqueous composition, the active agents of which are extracted from edible fungi (parasol mushroom, pleurotus, button mushroom). An alkaline extraction is carried out, then an enzymatic hydrolysis, to obtain a fraction less than 100 kDa. The process consists in spraying the aerial parts of the plant with the composition obtained in this way; this thereby acts to combat cryptogamic diseases of plants such as vines, fruit trees, vegetable crops and cereals.
    Type: Grant
    Filed: October 13, 2017
    Date of Patent: June 20, 2023
    Assignee: UNIVERSITE DE LIMOGES
    Inventors: Céline Faugeron, Vincent Gloaguen, Cédric Astier, Charlotte Moine
  • Patent number: 11678665
    Abstract: The present invention relates to herbicidal) active pyridyl-/pyrimidyl-pyrazine derivatives, as well as to processes and intermediates used for the preparation of such derivatives. The invention further extends to herbicidal compositions comprising such derivatives, as well as to the use of such compounds and compositions in controlling undesirable plant growth: in particular the use in controlling weeds, in crops of useful plants.
    Type: Grant
    Filed: September 18, 2018
    Date of Patent: June 20, 2023
    Assignee: Syngenta Participations AG
    Inventors: Jeffrey Steven Wailes, Neil Brian Carter, John Martin Clough, John Williams
  • Patent number: 11679099
    Abstract: The present disclosure relates a method of treating chondrosarcoma or suppressing metastasis or recurrence thereof by regulating HIF-2?. The present method can be effectively used for treating chondrosarcoma or suppressing metastasis or recurrence thereof by inhibiting HIF-2? during the development and metastasis of chondrosarcoma, particularly dedifferentiated chondrosarcoma.
    Type: Grant
    Filed: May 13, 2020
    Date of Patent: June 20, 2023
    Assignee: SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
    Inventors: Jin-Hong Kim, Hyeonkyeong Kim, Hyeon-Seop Kim, Yongsik Cho
  • Patent number: 11661433
    Abstract: Near-infrared activatable fluorescent small molecules for the photodynamic treatment of cancer are provided. Methods of treatment include contacting a plurality of cells of the cancer with a near-infrared activatable fluorescent small molecule and directing a near-IR light to the molecule for an amount of time sufficient to induce release of the active platinum species and a reactive oxygen species.
    Type: Grant
    Filed: May 9, 2019
    Date of Patent: May 30, 2023
    Assignee: VIRGINIA COMMONWEALTH UNIVERSITY
    Inventors: Matthew Hartman, Koushambi Mitra
  • Patent number: 11633415
    Abstract: The present invention includes CSNK1A1 inhibitors that are useful in treating or preventing a cancer in a subject. In certain embodiments, the cancer comprises a hematological cancer, such as but not limited to acute myeloid leukemia (AML) and/or MDS (myelodysplastic syndrome, including 5q-MDS). In other embodiments, the cancer comprises colon cancer.
    Type: Grant
    Filed: March 30, 2018
    Date of Patent: April 25, 2023
    Assignees: THE BROAD INSTITUTE, INC., DANA-FARBER CANCER INSTITUTE, INC.
    Inventors: Steven M. Corsello, Todd R. Golub, Eric Stefan, Robert Hilgraf